1. 3035 Vascular Disrupting Agent ASA 404 evaluated in human isolated ventilated and perfused lung lobes containing NSCLC. (September 2015) Authors: Hohenberger, P.; Elleni, S.; Marc, F.; Eva, R.; Peter, F.; Alexander, M.; Benito, Y.; Nowak, K. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S608 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adherence to oral antineoplastic agents by cancer patients: definition and literature review. (15th September 2013) Authors: Bassan, F.; Peter, F.; Houbre, B.; Brennstuhl, M.J.; Costantini, M.; Speyer, E.; Tarquinio, C. Journal: European journal of cancer care Issue: Volume 23:Number 1(2014:Jan.) Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗